Edition:
United Kingdom

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

23.58EUR
10 Dec 2018
Change (% chg)

€-0.82 (-3.36%)
Prev Close
€24.40
Open
€24.27
Day's High
€24.33
Day's Low
€23.58
Volume
667,212
Avg. Vol
684,622
52-wk High
€28.07
52-wk Low
€21.50

Chart for

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

Beta: 0.53
Market Cap(Mil.): €15,167.80
Shares Outstanding(Mil.): 687.55
Dividend: 0.14
Yield (%): 1.29

Financials

  GRLS.MC Industry Sector
P/E (TTM): 29.70 31.13 33.63
EPS (TTM): 0.82 -- --
ROI: 5.94 15.55 15.02
ROE: 16.00 16.92 16.60

BRIEF-Grifols Says AMBAR Results Show Reduction In Progression of Moderate Alzheimer's Disease

* SAID ON SATURDAY THAT AMBAR CLINICAL TRIAL DEMONSTRATED THE ABILITY TO SLOW DOWN THE PROGRESSION OF THE DISEASE IN MODERATE ALZHEIMER'S DISEASE (AD) PATIENTS

29 Oct 2018

Spanish stocks - Factors to watch on Thursday

The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

11 Oct 2018

Healthcare firm Grifols S.A. wins U.S. antitrust nod to buy Biotest US Corp

WASHINGTON Global healthcare company, Grifols S.A. , which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

01 Aug 2018

Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp

WASHINGTON, Aug 1 Global healthcare company, Grifols S.A., which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

01 Aug 2018

Earnings vs. Estimates